Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 71.45

+2.8%

Nov 10 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (33)	9/18/2002 2:54:21 PM
From: Jibacoa	Read Replies (1) of 3722

ARIA Had a good up-gap today after it announced at Bear Stearns Healthcare Conference that it had two new "potential" <g> products to treat cancer. The stock is still up 6.28% with the volume over 1.137 million compared to its 78.9K daily average. The wire services made echo of the news: biz.yahoo.com biz.yahoo.com biz.yahoo.com One of Ariad's two new product candidates, dubbed AP23675, is designed to treat both primary bone cancer and metastases to bone. The other product candidate Ariad discussed, AP23464, is designed to stop the progression and spread of solid tumors, such as colon cancers. siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next